Please use this identifier to cite or link to this item:
|Title:||Assessing the risk of exposures to endocrine disrupting chemicals|
|Authors:||MUNN SHARON; HEINDEL Jerry J.|
|Citation:||CHEMOSPHERE vol. 93 no. 6 p. 845-846|
|Publisher:||PERGAMON-ELSEVIER SCIENCE LTD|
|Type:||Articles in periodicals and books|
|Abstract:||The risk assessment process has been guided by principles of toxicology since it was developed some 50 years ago. These principles posit that toxicity decreases with decreasing doses. Thus, toxicity studies typically test chemicals starting at high doses and proceeding to progressively lower doses aiming to identify a dose at which no adverse effects are observed and extrapolating to predicted safe doses using additional factors to account for uncertainties in the accuracy of the animal model and test conditions. Thus the predicted safe dose is calculated but not tested. Over the last twenty years or so scientists have developed data showing that certain chemicals that disrupt endocrine signaling, e.g. endocrine disrupting Chemicals (EDCs), can act at low doses (in the range of low level environmentally relevant human exposures) in animal studies, and may show dose responses where the slope of the response changes direction i.e. non-monotonic dose responses (NMDR). If this scenario is true, the assumption that lower levels are safer may not be always correct.|
|JRC Directorate:||Institute for Health and Consumer Protection Historical Collection|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.